[1] Stone JH, Zen Y, Deshpande V. IgG4-related disease[J]. N Engl Med, 2012,366(6):539~551. [2] Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease[J].Gastroenterol, 2003,38(10):982~984. [3] Brito-Zerón P, Ramos-Casals M, Bosch X, et al. The clinical spectrum of IgG4-related disease[J]. Autoimmun Rev, 2014,13(12):1203~1210. [4] Umehara H, Okazaki K, Masaki Y, et al. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details[J]. Mod Rheumatol, 2012,22(1):1~14. [5] Kamisawa T, Zen Y, Pillai S, et al. IgG4-related disease[J]. Lancet, 2015,385(9976):1460~1471. [6] Raina A, Yadav D, Krasinskas AM, et al. Evaluation and management of autoimmune pancreatitis: experience at a large US center[J]. Am Gastroenterol, 2009,104(9):2295~2306. [7] Yamamoto M, Takahashi H, Shinomura Y. Mechanisms and assessment of IgG4-related disease: lessons for the rheumatologist[J]. Nat Rev Rheumatol, 2014,10(3):148~159. [8] Mahajan VS, Mattoo H, Deshpande V, et al. IgG4-related disease[J]. Annu Rev Pathol, 2014,9:315~347. [9] Della-Torre E, Lanzillotta M, Doglioni C. Immunology of IgG4-related disease[J]. Clin Exp Immunol, 2015,181(2):191~206. [10] Zen Y, Nakanuma Y. Pathogenesis of IgG4-related disease[J]. Curr Opin Rheumatol, 2011,23(1):114~118. [11] Pieringer H, Parzer I, Wohrer A, et al. IgG4- related disease: an orphan disease with many faces[J]. Orphanet Rare Dis, 2014,9:110. [12] de Buy Wenniger LJ M, Beuers U. Immunoglobulin G4-related cholangiopathy: clinical and experimental insights[J]. Curr Opin Gastroenterol, 2015,31(3):252~257. [13] Kawa S, Ota M, Yoshizawa K, et al. HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population[J]. Gastroenterology, 2002,122(5):1264~1269. [14] 于立杰, 陈雨, 张盼盼, 等. igg4相关疾病与人类白细胞抗原-dr、dq等位基因的相关性[J].中华临床免疫和变态反应杂志,2016,10(4):346~350. [15] Frulloni L, Lunardi C, Simone R, et al. Identification of a novel antibody associated with autoimmune pancreatitis[J]. N Engl Med, 2009,361(22):2135~2142. [16] Culver EL, Smit WL, Evans C, et al. No evidence to support a role for Helicobacter pylori infection and plasminogen binding protein in autoimmune pancreatitis and IgG4-related disease in a UK cohort[J]. Pancreatology, 2017. [17] Della TE, Mattoo H, Mahajan VS, et al. Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease[J]. Allergy, 2014,69(2):269~272. [18] Wallace ZS, Deshpande V, Mattoo H, et al. IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients[J]. Arthritis Rheumatol, 2015,67(9):2466~2475. [19] Carruthers MN, Khosroshahi A, Augustin T, et al. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease[J]. Ann Rheum Dis, 2015,74(1):14~18. [20] Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease[J]. Mod Pathol, 2012,25(9):1181~1192. [21] Khosroshahi A, Wallace ZS, Crowe JL, et al. International consensus guidance statement on the management and treatment of IgG4-related disease[J]. Arthritis Rheumatol, 2015,67(7):1688~1699. [22] Umehara H, Okazaki K, Kawano M, et al. How to diagnose IgG4-related disease[J]. Ann Rheum Dis, 2017. [23] Kamisawa T, Okazaki K, Kawa S, et al. Amendment of the japanese consensus guidelines for autoimmune pancreatitis, 2013 III. treatment and prognosis of autoimmune pancreatitis[J]. Gastroenterol, 2014,49(6):961~970. [24] Hart PA, Topazian MD, Witzig TE, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience[J]. Gut, 2013,62(11):1607~1615.
2017, Vol. 23 
冀公网安备13080202000677号